The dawn of in vivo immune cell engineering in oncology

Nature Biotechnology 2026

View at publisher
Authors: Adrian Bot, Matthias T. Stephan, Saar Gill
DOI: 10.1038/s41587-025-02979-0
Cited by: 3
References: 25

Fields of Study & Subjects

CAR-T cell therapy research Nanoplatforms for cancer theranostics Phagocytosis and Immune Regulation

Publication details

Journal / source
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Volume
44
Issue
2
Pages
177–180
Publication date
22 January 2026
Language
EN